The global NLP in healthcare and life sciences market is projected to grow from USD 7.8 billion in 2026 to USD 33.2 billion by 2036, at a 15.6% CAGR. Commercial adoption depends on connecting extraction, classification, summarization, or search to a defined clinical, coding, or research workflow with an authorized reviewer. Certified health IT supports care delivered by more than 96% of hospitals and 78% of office-based physicians, making EHR integration, source traceability, and model-governance evidence practical purchasing requirements. Software is projected at 53.0% share in 2026, while clinical documentation is estimated at 29.0% of application demand. Cloud-based deployment is forecast at 64.0% in 2026. Validation, privacy controls, and terminology coverage limit adoption when output cannot be traced, corrected, or approved. Key players include Microsoft Corporation, Oracle Health, IQVIA Holdings Inc., Amazon Web Services (AWS), Google Cloud, Solventum Corporation, NVIDIA Corporation, SAS Institute Inc., John Snow Labs, and IBM Corporation. The market is segmented by component, application, deployment, end user, technology, and region.